BBC News: GlaxoSmithKline is seeking regulatory approval for the world’s first vaccine against malaria, after promising trial data showed that it cut cases of the often-fatal disease in African children.
The company has been developing the vaccine for 3 decades and plans to submit a regulatory application to the European Medicines Agency.
Malaria kills hundreds of thousands of people every year.
Photo: Malaria infected mosquitoes (AFP)
The vaccine has only modest efficacy compared to other approved immunizations. And it’s a bit costly. But still, it has the potential to save hundreds of thousands of lives each year – which is great progress